These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


361 related items for PubMed ID: 15885610

  • 1. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
    Vulliamy TJ, Walne A, Baskaradas A, Mason PJ, Marrone A, Dokal I.
    Blood Cells Mol Dis; 2005; 34(3):257-63. PubMed ID: 15885610
    [Abstract] [Full Text] [Related]

  • 2. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.
    Yamaguchi H, Calado RT, Ly H, Kajigaya S, Baerlocher GM, Chanock SJ, Lansdorp PM, Young NS.
    N Engl J Med; 2005 Apr 07; 352(14):1413-24. PubMed ID: 15814878
    [Abstract] [Full Text] [Related]

  • 3. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.
    Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I.
    Nat Genet; 2004 May 07; 36(5):447-9. PubMed ID: 15098033
    [Abstract] [Full Text] [Related]

  • 4. Stem cells, telomerase and dyskeratosis congenita.
    Mason PJ.
    Bioessays; 2003 Feb 07; 25(2):126-33. PubMed ID: 12539238
    [Abstract] [Full Text] [Related]

  • 5. TERC mutations in children with refractory cytopenia.
    Ortmann CA, Niemeyer CM, Wawer A, Ebell W, Baumann I, Kratz CP.
    Haematologica; 2006 May 07; 91(5):707-8. PubMed ID: 16670076
    [Abstract] [Full Text] [Related]

  • 6. Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome.
    Field JJ, Mason PJ, An P, Kasai Y, McLellan M, Jaeger S, Barnes YJ, King AA, Bessler M, Wilson DB.
    J Pediatr Hematol Oncol; 2006 Jul 07; 28(7):450-3. PubMed ID: 16825992
    [Abstract] [Full Text] [Related]

  • 7. Mutations in telomerase catalytic protein in Japanese children with aplastic anemia.
    Liang J, Yagasaki H, Kamachi Y, Hama A, Matsumoto K, Kato K, Kudo K, Kojima S.
    Haematologica; 2006 May 07; 91(5):656-8. PubMed ID: 16627250
    [Abstract] [Full Text] [Related]

  • 8. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.
    de la Fuente J, Dokal I.
    Pediatr Transplant; 2007 Sep 07; 11(6):584-94. PubMed ID: 17663679
    [Abstract] [Full Text] [Related]

  • 9. Telomerase gene mutation screening in Chinese patients with aplastic anemia.
    Han B, Liu B, Cui W, Wang X, Lin J, Zhao Y.
    Leuk Res; 2010 Feb 07; 34(2):258-60. PubMed ID: 19942288
    [Abstract] [Full Text] [Related]

  • 10. Dyskeratosis congenita: telomerase, telomeres and anticipation.
    Marrone A, Walne A, Dokal I.
    Curr Opin Genet Dev; 2005 Jun 07; 15(3):249-57. PubMed ID: 15917199
    [Abstract] [Full Text] [Related]

  • 11. Dyskeratosis congenita.
    Vulliamy T, Dokal I.
    Semin Hematol; 2006 Jul 07; 43(3):157-66. PubMed ID: 16822458
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
    Marrone A, Dokal I.
    Expert Rev Mol Med; 2004 Dec 20; 6(26):1-23. PubMed ID: 15613268
    [Abstract] [Full Text] [Related]

  • 14. Telomeres and marrow failure.
    Calado RT.
    Hematology Am Soc Hematol Educ Program; 2009 Dec 20; ():338-43. PubMed ID: 20008219
    [Abstract] [Full Text] [Related]

  • 15. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA.
    Fogarty PF, Yamaguchi H, Wiestner A, Baerlocher GM, Sloand E, Zeng WS, Read EJ, Lansdorp PM, Young NS.
    Lancet; 2003 Nov 15; 362(9396):1628-30. PubMed ID: 14630445
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. NOLA1 gene mutations in acquired aplastic anemia.
    Pigullo S, Pavesi E, Dianzani I, Santamaria G, Svahn J, Risso M, Van Lint MT, Pillon M, Iori AP, Longoni D, Ramenghi U, Lanciotti M, Dufour C.
    Pediatr Blood Cancer; 2009 Mar 15; 52(3):376-8. PubMed ID: 18989882
    [Abstract] [Full Text] [Related]

  • 18. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
    Savage SA, Stewart BJ, Weksler BB, Baerlocher GM, Lansdorp PM, Chanock SJ, Alter BP.
    Blood Cells Mol Dis; 2006 Mar 15; 37(2):134-6. PubMed ID: 16934504
    [No Abstract] [Full Text] [Related]

  • 19. Telomere length variation and telomerase activity expression in patients with congenital and acquired aplastic anemia.
    Polychronopoulou S, Koutroumba P.
    Acta Haematol; 2004 Mar 15; 111(3):125-31. PubMed ID: 15034232
    [Abstract] [Full Text] [Related]

  • 20. Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations.
    Marrone A, Sokhal P, Walne A, Beswick R, Kirwan M, Killick S, Williams M, Marsh J, Vulliamy T, Dokal I.
    Haematologica; 2007 Aug 15; 92(8):1013-20. PubMed ID: 17640862
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.